EBITDA Summary of Sanofi

Sanofi's latest annual EBITDA in 2023 was 12.6 Billion EUR , down -5.89% from previous year.
Sanofi's latest quarterly EBITDA in 2024 Q2 was 6.06 Billion EUR , down -6.29% from previous quarter.
Sanofi reported an annual EBITDA of 13.77 Billion EUR in 2022, up 27.95% from previous year.
Sanofi reported an annual EBITDA of 11.53 Billion EUR in 2021, up 10.23% from previous year.
Sanofi reported a quarterly EBITDA of 2.86 Billion EUR for 2024 Q1, up 31.47% from previous quarter.
Sanofi reported a quarterly EBITDA of 6.06 Billion EUR for 2024 Q2, down -6.29% from previous quarter.

Annual EBITDA Chart of Sanofi (2023 - 1999)

Historical Annual EBITDA of Sanofi (2023 - 1999)

Year	EBITDA	EBITDA Growth
2023	12.6 Billion EUR	-5.89%
2022	13.77 Billion EUR	27.95%
2021	11.53 Billion EUR	10.23%
2020	17.88 Billion EUR	-0.78%
2019	10.66 Billion EUR	8.24%
2018	9.17 Billion EUR	1.02%
2017	9.63 Billion EUR	-5.27%
2016	9.9 Billion EUR	0.55%
2015	10.07 Billion EUR	-0.61%
2014	9.53 Billion EUR	0.04%
2013	9.5 Billion EUR	-14.94%
2012	11.43 Billion EUR	4.98%
2011	10.64 Billion EUR	-6.66%
2010	11.77 Billion EUR	0.26%
2009	11.4 Billion EUR	13.62%
2008	10.48 Billion EUR	-3.8%
2007	10.4 Billion EUR	-16.53%
2006	12.11 Billion EUR	-6.95%
2005	11.66 Billion EUR	494.27%
2004	2.25 Billion EUR	-29.29%
2003	3.45 Billion EUR	14.03%
2002	2.99 Billion EUR	16.12%
2001	2.4 Billion EUR	32.4%
2000	1.81 Billion EUR	50.62%
1999	1.2 Billion EUR	0.0%

Year	EBITDA	EBITDA Growth
2024 Q3	4.24 Billion EUR	109.62%
2024 Q1	2.86 Billion EUR	31.47%
2024 Q2	6.06 Billion EUR	-6.29%
2023 Q3	4.16 Billion EUR	46.84%
2023 Q4	7.76 Billion EUR	86.68%
2023 Q1	3.38 Billion EUR	24.79%
2023 FY	- EUR	-5.89%
2023 Q2	2.83 Billion EUR	-16.26%
2022 Q1	3.03 Billion EUR	34.76%
2022 Q2	2.63 Billion EUR	-13.03%
2022 Q3	5.16 Billion EUR	95.83%
2022 Q4	2.71 Billion EUR	-47.5%
2022 FY	- EUR	27.95%
2021 Q2	2.28 Billion EUR	-13.94%
2021 Q3	3.59 Billion EUR	57.11%
2021 Q4	2.25 Billion EUR	-37.33%
2021 FY	- EUR	10.23%
2021 Q1	2.65 Billion EUR	28.7%
2020 Q1	2.66 Billion EUR	23.84%
2020 Q2	1.86 Billion EUR	-29.98%
2020 Q3	3.44 Billion EUR	84.45%
2020 FY	- EUR	-0.78%
2020 Q4	2.06 Billion EUR	-40.06%
2019 Q2	2.43 Billion EUR	6.61%
2019 Q1	2.28 Billion EUR	36.93%
2019 FY	- EUR	8.24%
2019 Q4	2.15 Billion EUR	-27.52%
2019 Q3	2.96 Billion EUR	21.93%
2018 Q1	2 Billion EUR	26.8%
2018 Q2	1.95 Billion EUR	-2.79%
2018 Q3	3.46 Billion EUR	77.79%
2018 Q4	1.66 Billion EUR	-51.89%
2018 FY	- EUR	1.02%
2017 Q1	2.4 Billion EUR	3.97%
2017 Q3	2.78 Billion EUR	24.66%
2017 Q4	1.58 Billion EUR	-43.09%
2017 FY	- EUR	-5.27%
2017 Q2	2.23 Billion EUR	-7.35%
2016 FY	- EUR	0.55%
2016 Q2	2.12 Billion EUR	-0.7%
2016 Q1	2.13 Billion EUR	-4.08%
2016 Q4	2.31 Billion EUR	-20.77%
2016 Q3	2.92 Billion EUR	37.57%
2015 Q3	2.75 Billion EUR	6.38%
2015 FY	- EUR	-0.61%
2015 Q1	2.43 Billion EUR	0.25%
2015 Q4	2.23 Billion EUR	-18.97%
2015 Q2	2.58 Billion EUR	6.2%
2014 Q2	2.2 Billion EUR	-3.21%
2014 Q1	2.27 Billion EUR	-10.9%
2014 FY	- EUR	0.04%
2014 Q3	2.6 Billion EUR	18.32%
2014 Q4	2.43 Billion EUR	-6.65%
2013 Q2	2.08 Billion EUR	-12.64%
2013 Q1	2.38 Billion EUR	12.31%
2013 FY	- EUR	-14.94%
2013 Q4	2.55 Billion EUR	2.16%
2013 Q3	2.49 Billion EUR	20.05%
2012 Q4	2.12 Billion EUR	-33.06%
2012 FY	- EUR	4.98%
2012 Q1	2.97 Billion EUR	12.35%
2012 Q3	3.16 Billion EUR	15.04%
2012 Q2	2.75 Billion EUR	-7.43%
2011 FY	- EUR	-6.66%
2011 Q4	2.64 Billion EUR	-18.48%
2011 Q1	2.27 Billion EUR	4.94%
2011 Q2	2.47 Billion EUR	9.03%
2011 Q3	3.24 Billion EUR	31.14%
2010 Q3	3.05 Billion EUR	-2.15%
2010 FY	- EUR	0.26%
2010 Q4	2.16 Billion EUR	-29.14%
2010 Q2	3.12 Billion EUR	1.96%
2010 Q1	3.06 Billion EUR	-64.61%
2009 Q1	2.96 Billion EUR	71.72%
2009 FY	- EUR	13.62%
2009 Q4	8.65 Billion EUR	885.19%
2009 Q3	878 Million EUR	-71.59%
2009 Q2	3.09 Billion EUR	4.08%
2008 Q1	2.52 Billion EUR	116.77%
2008 FY	- EUR	-3.8%
2008 Q4	1.72 Billion EUR	-36.2%
2008 Q3	2.71 Billion EUR	7.53%
2008 Q2	2.52 Billion EUR	-0.03%
2007 FY	- EUR	-16.53%
2007 Q3	6.96 Billion EUR	175.14%
2007 Q2	2.53 Billion EUR	-64.1%
2007 Q1	7.05 Billion EUR	143.83%
2007 Q4	-15.03 Billion EUR	-315.67%
2006 Q2	2.43 Billion EUR	-36.32%
2006 FY	- EUR	-6.95%
2006 Q1	3.82 Billion EUR	304.93%
2006 Q4	-16.09 Billion EUR	-318.87%
2006 Q3	7.35 Billion EUR	201.73%
2005 Q2	2.73 Billion EUR	-32.44%
2005 Q4	-1.86 Billion EUR	-140.09%
2005 Q3	4.65 Billion EUR	70.24%
2005 Q1	4.05 Billion EUR	140.47%
2005 FY	- EUR	494.27%
2004 Q1	2.22 Billion EUR	169.76%
2004 FY	- EUR	-29.29%
2004 Q3	5.33 Billion EUR	543.01%
2004 Q2	829.67 Million EUR	-62.75%
2004 Q4	-10.01 Billion EUR	-287.64%
2003 Q1	1.94 Billion EUR	165.94%
2003 Q2	729.18 Million EUR	-64.18%
2003 Q3	2.41 Billion EUR	246.82%
2003 Q4	-3.19 Billion EUR	-232.07%
2003 FY	- EUR	14.03%
2002 Q3	1.87 Billion EUR	210.89%
2002 Q2	644.22 Million EUR	0.0%
2002 FY	- EUR	16.12%
2002 Q4	-2.95 Billion EUR	-257.68%
2001 FY	- EUR	32.4%
2000 FY	- EUR	50.62%
1999 FY	- EUR	0.0%

Peer EBITDA Comparison of Sanofi

Name	EBITDA	EBITDA Difference
AstraZeneca PLC	13.28 Billion USD	5.159%
Bristol-Myers Squibb Company PFD CONV 2	19.41 Billion USD	35.088%
CSPC Pharmaceutical Group Limited	1.14 Billion USD	-997.847%
Clarus Therapeutics Holdings, Inc.	-39.7 Million USD	31844.113%
Novartis AG	19.51 Billion USD	35.423%
PT Kalbe Farma Tbk.	288.13 Million USD	-4274.358%

Global Stocks Search

Sanofi (SNYNF)

EBITDA Summary of Sanofi

Annual EBITDA Chart of Sanofi (2023 - 1999)

Historical Annual EBITDA of Sanofi (2023 - 1999)

Peer EBITDA Comparison of Sanofi